BlackRock Health Sciences Trust Stock
BlackRock Health Sciences Trust Stock price
Key metrics
| Market capitalization | $520.98m |
| Enterprise Value | $502.08m |
| EV/FCF (TTM) EV/FCF | negative |
| EV/Sales (TTM) EV/Sales | 28.03 |
| P/S ratio (TTM) P/S ratio | 29.09 |
| Dividend yield | 6.67% |
| Last dividend (FY24) | $2.56 |
| Revenue growth (TTM) Revenue growth | 4.45% |
| Revenue (TTM) Revenue | $17.91m |
Is BlackRock Health Sciences Trust a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
Financial data from BlackRock Health Sciences Trust
| Jun '24 |
+/-
%
|
||
| Revenue | 18 18 |
4%
4%
|
|
| Gross Profit | 12 12 |
6%
6%
|
|
| EBITDA | 55 55 |
16%
16%
|
EBIT (Operating Income) EBIT | 55 55 |
16%
16%
|
| Net Profit | 55 55 |
16%
16%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about BlackRock Health Sciences Trust directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
BlackRock Health Sciences Trust Stock News
Company Profile
BlackRock Health Sciences Trust is a closed-end investment fund. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The company was founded on March 31, 2005 and is headquartered in Wilmington, DE.
| Head office | United States |
| CEO | John Perlowski |
| Founded | 2005 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
